In addition, the expression of TUNEL-positive cells was significantly amplified, while the expression of PCNA-positive cells was dramatically reduced in the tumor tissue with combined treatment of radotinib and Ara-C (Fig. 6f-g). The gene discussed is PCNA; the disease is neoplasm.